Public Employees Retirement Association of Colorado lowered its position in shares of UnitedHealth Group Inc. (NYSE:UNH) by 1.3% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 735,803 shares of the healthcare conglomerate’s stock after selling 9,613 shares during the period. UnitedHealth Group accounts for 0.9% of Public Employees Retirement Association of Colorado’s investment portfolio, making the stock its 22nd largest position. Public Employees Retirement Association of Colorado’s holdings in UnitedHealth Group were worth $103,895,000 as of its most recent filing with the SEC.
A number of other institutional investors have also recently made changes to their positions in UNH. Benjamin F. Edwards & Company Inc. boosted its position in shares of UnitedHealth Group by 91.8% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 1,082 shares of the healthcare conglomerate’s stock worth $153,000 after buying an additional 518 shares during the period. Evanson Asset Management LLC bought a new position in shares of UnitedHealth Group during the second quarter valued at about $201,000. Parametrica Management Ltd bought a new position in shares of UnitedHealth Group during the second quarter valued at about $201,000. Franklin Street Advisors Inc. NC bought a new position in shares of UnitedHealth Group during the second quarter valued at about $208,000. Finally, Financial Architects Inc boosted its position in shares of UnitedHealth Group by 23.0% in the second quarter. Financial Architects Inc now owns 1,558 shares of the healthcare conglomerate’s stock valued at $220,000 after buying an additional 291 shares during the last quarter. Institutional investors own 85.78% of the company’s stock.
UnitedHealth Group Inc. (NYSE:UNH) traded up 0.96% during mid-day trading on Monday, hitting $137.97. The company had a trading volume of 1,571,863 shares. UnitedHealth Group Inc. has a 52-week low of $107.51 and a 52-week high of $144.48. The stock’s 50 day moving average price is $137.80 and its 200 day moving average price is $136.35. The firm has a market cap of $131.40 billion, a P/E ratio of 21.59 and a beta of 0.57.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.89 by $0.07. The firm earned $46.50 billion during the quarter, compared to analyst estimates of $45.05 billion. UnitedHealth Group had a return on equity of 19.08% and a net margin of 3.51%. On average, equities research analysts predict that UnitedHealth Group Inc. will post $7.90 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Friday, September 9th were paid a dividend of $0.625 per share. This represents a $2.50 dividend on an annualized basis and a yield of 1.81%. The ex-dividend date was Tuesday, September 6th. UnitedHealth Group’s payout ratio is currently 39.12%.
Several brokerages have recently issued reports on UNH. Barclays PLC lifted their price objective on UnitedHealth Group from $151.00 to $164.00 and gave the company an “overweight” rating in a research note on Wednesday, July 20th. Royal Bank Of Canada lifted their price objective on UnitedHealth Group from $157.00 to $165.00 and gave the company an “outperform” rating in a research note on Wednesday, July 20th. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $160.00 price objective for the company in a research note on Friday, July 22nd. Mizuho lifted their price objective on UnitedHealth Group from $156.00 to $160.00 and gave the company a “buy” rating in a research note on Tuesday, July 19th. Finally, Sanford C. Bernstein began coverage on UnitedHealth Group in a research note on Wednesday, June 15th. They issued an “outperform” rating and a $171.00 price objective for the company. One analyst has rated the stock with a hold rating, twenty-five have given a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus target price of $155.35.
In other UnitedHealth Group news, Director Richard T. Burke sold 40,000 shares of the stock in a transaction on Wednesday, September 7th. The stock was sold at an average price of $135.31, for a total transaction of $5,412,400.00. Following the completion of the transaction, the director now directly owns 2,003,550 shares of the company’s stock, valued at approximately $271,100,350.50. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 1.65% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc. (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.